EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential

EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential

Item
http://www.wikidata.org/entity/Q28484249
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalNeuraminidase-1: a novel therapeutic target in multistage tumorigenesisE1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factorGene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation modelA randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancerPotential Therapeutic Targets in Uterine Sarcomas.Targeting protein kinases to reverse multidrug resistance in sarcoma.Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression.Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma.Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.Cancer stem cells: are they responsible for treatment failure?Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance.Approaches for targeting cancer stem cells drug resistance.The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.A review of soft-tissue sarcomas: translation of biological advances into treatment measures.Soft Tissue Sarcoma Cancer Stem Cells: An Overview
P2860

EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential

Item
http://www.wikidata.org/entity/Q28484249
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@ast
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@en
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@nl
type
label
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@ast
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@en
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@nl
prefLabel
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@ast
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@en
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P3181
P356
P1433
P1476
EGFR inhibition abrogates leio ...... nd impairment of CSC potential
@en
P2093
P2860
P304
P31
P3181
P356
10.1371/JOURNAL.PONE.0046891
P407
P433
P478
P50
P577
P5875
P698
P932